Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Language and geographical location influence the incidence of chronic cough in the Canadian Longitudinal Study on Aging

Imran Satia, Alexandra J. Mayhew, Nazmul Sohel, Om Kurmi, Kieran J. Killian, Megan E. O'Connell, Paul M. O'Byrne, Parminder Raina
ERJ Open Research 2022 8: 00721-2021; DOI: 10.1183/23120541.00721-2021
Imran Satia
1McMaster University, Dept of Medicine, Hamilton, ON, Canada
2Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada
3Dept of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
4McMaster Institute for Research on Ageing, McMaster University, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Imran Satia
  • For correspondence: satiai@mcmaster.ca
Alexandra J. Mayhew
3Dept of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
4McMaster Institute for Research on Ageing, McMaster University, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nazmul Sohel
3Dept of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
4McMaster Institute for Research on Ageing, McMaster University, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Om Kurmi
1McMaster University, Dept of Medicine, Hamilton, ON, Canada
2Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada
3Dept of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
5Faculty of Health and Life Sciences, Coventry University, Coventry, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kieran J. Killian
1McMaster University, Dept of Medicine, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan E. O'Connell
6Faculty of Psychology and Health Studies, University of Saskatchewan, Saskatoon, SK, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul M. O'Byrne
1McMaster University, Dept of Medicine, Hamilton, ON, Canada
2Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul M. O'Byrne
Parminder Raina
3Dept of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
4McMaster Institute for Research on Ageing, McMaster University, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

French speakers have a 4% lower incidence of chronic cough than English speakers in the CLSA, but English speakers from Quebec, Newfoundland and Labrador, and Nova Scotia also have a lower risk of developing chronic cough https://bit.ly/3qAd3Mf

To the Editor:

The prevalence of chronic cough is highly variable globally ranging from 2% to 18% [1]. The prevalence was higher in Australia, Europe, America (11–18%) and much lower in Asia (4%) and Africa (2%), even after adjusting for smoking. The majority of the studies used the 3-month chronic bronchitis definition, but even in studies using the same 8-week cut-off, variations still persist: UK (12%) [2], Finland (7.2%) [3], Germany (5%) [4], Denmark (4%) [5], South Korea (2.6%) [6], Japan (2.2%) [7], Nigeria (1.1%) [8]. The reasons for these variations, even in geographically similar countries, are unclear.

The prevalence of chronic cough in the Canadian Longitudinal Study on Ageing (CLSA) is 16%, but is lower in Quebec (10.4%) than in Ontario (15.8%) [9]. We therefore investigated whether language (English versus French) or geographical location (provinces) influences the prevalence and incidence of chronic cough independent of age, sex, smoking, body max index (BMI), respiratory diseases and self-perceived general health.

The CLSA is a large, nationally generalisable, stratified random sample of Canadians aged 45–85 years at baseline (2011–2015) from the 10 Canadian provinces and followed every 3 years until 2033 or death [9–11]. The first follow-up was conducted between 2015 and 2018. Only the first follow-up was included in the current analyses. This study was approved by the Hamilton integrated Research Ethics Board and by the CLSA scientific advisory board (Project ID:1909024).

Chronic cough was defined as a daily cough on most days within the past 12 months. Prevalent chronic cough was categorised as having a chronic cough at baseline, whilst incident chronic cough referred to those who developed chronic cough at follow-up 3 years later. Participants in Ontario and Quebec were given the choice to complete the interview in English or French. The language used to complete the questionnaire was used as the dominant language of the subject in this study.

Covariates which impact the incidence of chronic cough were included in the core model: age, sex, smoking status, BMI, province, self-reported general health, and physician-diagnosed respiratory airways diseases (asthma, COPD). Participants who reported no chronic cough at baseline were considered for incidental chronic cough at follow-up 1. We employed Proc GENMOD in SAS (version 9.4; SAS Institute Inc., Cary, NC, USA) with Poisson distribution and log link for calculating the multivariable relative risk (RR) and to assess the association of all covariates with the outcomes of incidental cough. The analyses were stratified by language (English versus French).

The CLSA comprehensive cohort included 30 097 participants. A total of 29 972 completed the chronic cough question at baseline, and 22 547 who did not report chronic cough at baseline completed the chronic cough question at follow-up. In the follow-up sample who did not report baseline cough, 17 863 (79.2%) were English speaking and 4684 (20.8%) were French speaking. The majority of participants in Quebec were French speaking (4441/4855, 91.5%), whilst in Ontario they were English speaking (4656/4899, 95.0%). There were no participants who were considered French speaking outside of Quebec and Ontario. Overall, 2506 (11.1%) participants reported chronic cough at follow-up, of whom 2131 (11.9%) were English speaking and 375 (8.0%) French speaking. The incidence of chronic cough was similar in French speaking participants residing in Quebec and Ontario (7.97% versus 8.64%, respectively, p=0.71). In contrast, the incidence of chronic cough in English speakers was 13.83% in Ontario, but lower in Quebec at 8.45% (p=0.002).

In English speaking participants, the risk of incident chronic cough was lower in Quebec (RR 0.59 (95% CI 0.42–0.83)), Nova Scotia (0.66 (0.56–0.78)), Newfoundland and Labrador (0.80 (0.68–0.94)), and British Columbia (0.87 (0.77–0.97)) compared with Ontario, after adjusting for other covariates (figure 1a). The risk of incident chronic cough was similar for Manitoba and Alberta compared with Ontario. Other variables associated with an increased risk of incident chronic cough were older age, being male, smoking (previous and current smokers), being overweight/obese compared to normal weight, poor or fair self-rated general health compared to good, very good, or excellent, and the presence of any chronic respiratory airways diseases.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Factors influencing the incidence of chronic cough stratified by speaking a) English and b) French. Core incidence model adjusted for time to follow-up 1 (RR 1.08 (95% CI 0.94–1.25)), age, sex, smoking status, body mass index (BMI), provinces, self-reported general health, and respiratory airways diseases. Point estimate and error bars show the mean estimated relative risk with 95% confidence intervals. Numerical values are also shown.

In French speaking participants, there was no difference in the risk of incident chronic cough living in Quebec compared with Ontario (figure 1b). Compared with English speaking participants, the risk of incident chronic cough did not increase with increasing age, in previous smokers and with being male, but the impact of respiratory diseases was higher in French speaking participants.

This is the largest national longitudinal study globally investigating chronic cough and provides novel insights about the influence of language and location on the incidence of chronic cough. This is a unique study because it recruited participants over a large geographical area across Canada who completed the same questions in either English or French, with a standardised data collection method. The results provide three important insights. 1) Overall, French speakers demonstrated a 4% lower incidence of chronic cough than English speakers. 2) Geographical location matters: English speakers living in Quebec, Nova Scotia, Newfoundland and Labrador, and British Columbia have a 41%, 33%, 20% and 13% lower risk of developing chronic cough compared with Ontario. 3) French speakers living in Ontario have a similar incidence of chronic cough to those living in Quebec.

There are a number of possible explanations for these results. First, the French population of Quebec, and English population of Newfoundland and Labrador are known to have a strong founder effect [12, 13]. Genetic factors may explain the lower incidence of chronic cough in French speakers, but also English speakers in Newfoundland and Labrador. Secondly, language represents cultural norms, expectations, values, behaviours, and willingness to disclose information which can differ across cultures and location. For example, fluent English speakers in England, North America, Europe, and India may not necessarily share the same beliefs and values and hence their cognitive interpretations and responses to questions may differ [14]. We have previously reported differences in the prevalence of chronic cough in different ethnicities and place of birth [9], but asking the same question in different languages may evoke different interpretation and responses. For example, epidemiological studies from within Europe (Copenhagen, Germany, Rotterdam [15] and Finland) that have conducted questionnaires in their own native languages demonstrate wide variability in the prevalence of chronic cough (4–11%) suggesting measurement using different languages could be a confounder. Third, Canada is large geographically with different weather and environmental exposures. Thus, differences in air quality, pollution, population density and climate across provinces require further exploration. Fourth, French speakers phonate differently to English speakers when speaking with the use of different parts of the larynx/pharynx. This may reduce laryngeal sensitivity which often occurs in patients with chronic cough. Fifth, language may also represent dietary differences across cultures which may influence chronic cough.

There are limitations to this study. First, some Canadians are bilingual, but we assumed the language the questionnaire was conducted in was the dominant language. Second, if the CLSA interviewer was not French speaking in Ontario, then English was used, hence the possibility of misclassification. Third, French was not offered outside of Quebec and Ontario. Fourth, these were small samples: 21 out of 243 participants living in Ontario that completed the questionnaire in French reported incident chronic cough and 35 out of 414 participants living in Quebec that completed the questionnaire in English reported incident chronic cough. Fifth, it is possible that between the baseline questionnaire and 3-year follow-up, there may have been movement between Quebec and Ontario which we have not accounted for.

In conclusion, these data suggest language and geographical location independently influence the incidence of chronic cough. Development of questionnaires, patient-reported outcomes and recruitment in clinical trials in chronic cough should be cognisant of these factors.

Acknowledgements

This research was made possible using the data/biospecimens collected by the Canadian Longitudinal Study on Aging (CLSA). Funding for the CLSA is provided by the Government of Canada through the Canadian Institutes of Health Research under grant reference LSA 94473 and the Canada Foundation for Innovation as well as the following provinces: Newfoundland, Nova Scotia, Quebec, Ontario, Manitoba, Alberta and British Columbia. This research has been conducted using the CLSA dataset, Baseline and Follow-up 1 Comprehensive Dataset, under Application Number 1909024. The CLSA is led by P. Raina, C. Wolfson and S. Kirkland. The opinions expressed in this manuscript are the author's own and do not reflect the views of the CLSA. The final manuscript was reviewed and approved by the Publication Review Committee of the CLSA.

Footnotes

  • Provenance: Submitted article, peer reviewed.

  • Author contributions: P. Raina had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. I. Satia, A.J. Mayhew, K.J. Killian, P.M. O'Byrne and P. Raina contributed substantially to the study concept and design. All authors made substantial contributions to the acquisition, analysis or interpretation of data for the manuscript. I. Satia, A.J. Mayhew and N. Sohel contributed substantially to drafting of the manuscript. All authors contributed to the critical revision of the manuscript for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Conflict of interest: I. Satia reports grants from the ERS Respire 3 Marie Curie Fellowship, grants and personal fees from Merck Canada, and personal fees from GSK, AstraZeneca and Genentech, outside the submitted work. P.M. O'Byrne reports grants and personal fees from AstraZeneca, personal fees from GSK, grants from Novartis, grants and personal fees from Medimmune, and personal fees from Chiesi, outside the submitted work. The other authors have no disclosures to report.

  • Support statement: This study was funded by Merck Canada as an investigator-initiated grant to I. Satia and P.M. O'Byrne. The study sponsor had no role in the design or conduct of the study; collection, management, analysis or interpretation of the data; preparation, review or approval of the manuscript; or the decision to submit the manuscript for publication. I. Satia is currently supported by the E.J. Moran Campbell Early Career Award, Dept of Medicine, McMaster University. Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received December 23, 2021.
  • Accepted January 7, 2022.
  • Copyright ©The authors 2022
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

References

  1. ↵
    1. Song W-J,
    2. Chang Y-S,
    3. Faruqi S, et al.
    The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 2015; 45: 1479–1481. doi:10.1183/09031936.00218714
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Ford AC,
    2. Forman D,
    3. Moayyedi P, et al.
    Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax 2006; 61: 975–979. doi:10.1136/thx.2006.060087
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Lätti AM,
    2. Pekkanen J,
    3. Koskela HO
    . Defining the risk factors for acute, subacute and chronic cough: a cross-sectional study in a Finnish adult employee population. BMJ Open 2018; 8: e022950. doi:10.1136/bmjopen-2018-022950
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Virchow JC,
    2. Fonseca E,
    3. Salmen H, et al.
    P56 Chronic cough in Germany: prevalence and patient characteristics. Thorax 2021; 76: A97. doi:10.1136/thorax-2021-BTSabstracts.166
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Colak Y,
    2. Nordestgaard BG,
    3. Laursen LC, et al.
    Risk factors for chronic cough among 14,669 individuals from the general population. Chest 2017; 152: 563–573. doi:10.1016/j.chest.2017.05.038
    OpenUrlPubMed
  6. ↵
    1. Kang M-G,
    2. Song W-J,
    3. Kim H-J, et al.
    Point prevalence and epidemiological characteristics of chronic cough in the general adult population: The Korean National Health and Nutrition Examination Survey 2010–2012. Medicine (Baltimore) 2017; 96: e6486. doi:10.1097/MD.0000000000006486
    OpenUrlPubMed
  7. ↵
    1. Fujimura M
    . Frequency of persistent cough and trends in seeking medical care and treatment—Results of an internet survey. Allergol Int 2012; 61: 573–581. doi:10.2332/allergolint.11-OA-0368
    OpenUrlCrossRefPubMed
  8. ↵
    1. Desalu O,
    2. Salami A,
    3. Fawibe A
    . Prevalence of cough among adults in an urban community in Nigeria. West Afr J Med 2011; 30: 337–341.
    OpenUrlPubMed
  9. ↵
    1. Satia I,
    2. Mayhew AJ,
    3. Sohel N, et al.
    Prevalence, incidence and characteristics of chronic cough among adults from the Canadian Longitudinal Study on Aging. ERJ Open Res 2021; 7: 00160-2021. doi:10.1183/23120541.00160-2021
    OpenUrl
    1. Raina PS,
    2. Wolfson C,
    3. Kirkland SA, et al.
    The Canadian longitudinal study on aging (CLSA). Can J Aging 2009; 28: 221–229. doi:10.1017/S0714980809990055
    OpenUrlCrossRefPubMed
  10. ↵
    1. Raina P,
    2. Wolfson C,
    3. Kirkland S, et al.
    Cohort profile: the Canadian longitudinal study on aging (CLSA). Int J Epidemiol 2019; 48: 1752–1753j. doi:10.1093/ije/dyz173
    OpenUrlCrossRefPubMed
  11. ↵
    1. Laberge AM,
    2. Michaud J,
    3. Richter A, et al.
    Population history and its impact on medical genetics in Quebec. Clin Genet 2005; 68: 287–301. doi:10.1111/j.1399-0004.2005.00497.x
    OpenUrlCrossRefPubMed
  12. ↵
    1. Rahman P,
    2. Jones A,
    3. Curtis J, et al.
    The Newfoundland population: a unique resource for genetic investigation of complex diseases. Hum Mol Genet 2003; 12: Suppl. 2, R167–R172. doi:10.1093/hmg/ddg257
    OpenUrlCrossRefPubMed
  13. ↵
    1. Hunt SM,
    2. Bhopal R
    . Self report in clinical and epidemiological studies with non-English speakers: the challenge of language and culture. J Epidemiol Community Health 2004; 58: 618–622. doi:10.1136/jech.2003.010074
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Arinze JT,
    2. de Roos EW,
    3. Karimi L, et al.
    Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study. ERJ Open Res 2020; 6: 00300-2019. doi:10.1183/23120541.00300-2019
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Vol 8 Issue 1 Table of Contents
ERJ Open Research: 8 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Language and geographical location influence the incidence of chronic cough in the Canadian Longitudinal Study on Aging
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Language and geographical location influence the incidence of chronic cough in the Canadian Longitudinal Study on Aging
Imran Satia, Alexandra J. Mayhew, Nazmul Sohel, Om Kurmi, Kieran J. Killian, Megan E. O'Connell, Paul M. O'Byrne, Parminder Raina
ERJ Open Research Jan 2022, 8 (1) 00721-2021; DOI: 10.1183/23120541.00721-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Language and geographical location influence the incidence of chronic cough in the Canadian Longitudinal Study on Aging
Imran Satia, Alexandra J. Mayhew, Nazmul Sohel, Om Kurmi, Kieran J. Killian, Megan E. O'Connell, Paul M. O'Byrne, Parminder Raina
ERJ Open Research Jan 2022, 8 (1) 00721-2021; DOI: 10.1183/23120541.00721-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Broadening the scope for three dimensional (3D) printed airway stents
  • Tracheal complications of mechanical ventilation for COVID-19: a plot twist for survivors
  • Diffuse panniculitis in a teen male with ZZ alpha1-antitrypsin deficiency
Show more Research letter

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society